TrialJournal of neurology2022

Amifampridine safety and efficacy in spinal muscular atrophy ambulatory patients: a randomized, placebo-controlled, crossover phase 2 trial.

Silvia Bonanno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.